Skip to main content
Recall Canary
Dextroamphetamine/Amphetamine Extended-Release Capsules
← Back to all recalls
DRUG RECALLMODERATE

Dextroamphetamine/Amphetamine Extended-Release Capsules

Lannett is recalling 5 mg Dextroamphetamine/Amphetamine ER capsules due to a labeling mix-up where capsules contain immediate-release pellets.

What to do

Stop using the affected medication and contact your pharmacist or healthcare provider for guidance on obtaining a replacement.

Posted
Updated
Recall No.
D-0660-2026
Agency
Firm
Lannett Company Inc.
Recall ID
99319
Status
ONGOING

Why it was recalled

Lannett Company is recalling 5 mg extended-release capsules because the product contains immediate-release pellets instead of the labeled extended-release formulation. This labeling mix-up may result in unintended dosing and therapeutic effects.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 5 mg, Rx Only, 100 capsules, Distributed by: Lannett Company, Inc., Philadelphia, PA 19136, NDC: 0527-0790-37.

Recall #
D-0660-2026

Where it was sold

Distributed nationwide.

Other recent recalls from Lannett Company Inc.

← Back to all recalls

Editorial summary by Recall Canary · last updated 2026-07-03 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification